GGrantIndex
← Leaderboards

Lorraine B Ware

Vanderbilt University Medical Center

$25,185,641
Attributed
$27,246,119
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,246,119 · 14

By mechanism

R01$11,220,706 · 5
U01$8,137,942 · 3
T32$3,502,350 · 1
K24$1,612,146 · 1
R33$1,461,247 · 1
R21$702,878 · 2

Top collaborators

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Lung

Research focus

LungFunctional DisorderPlasmaClinical TrialsInjuryAdult Respiratory Distress SyndromeSepsisLeadCellsAcuteOrganLiquid SubstanceClinical ResearchPermeabilityCritical IllnessResearch PersonnelInflammationLung InjuryLung TransplantationProteinsEndotheliumBiological MarkersHemoglobinEnrollment

Grant awards (63)

The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$728,344
R33 · FY2025 · GM
The MUltidimenSional phenotyping In Critical care (MUSIC) Consortium: A pathway to precision medicine at the bedside$637,819
U01 · FY2025 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$474,260
T32 · FY2025 · HL · contact PI
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis$431,046
R01 · FY2025 · HL · contact PI
The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$732,903
R33 · FY2024 · GM
Haptoglobin 2 variant and endothelial glycocalyx shedding in sepsis-induced ARDS$549,637
R01 · FY2024 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$478,860
T32 · FY2024 · HL · contact PI
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis$431,046
R01 · FY2024 · HL · contact PI
The MUltidimenSional phenotyping In Critical care (MUSIC) Consortium: A pathway to precision medicine at the bedside$330,457
U01 · FY2024 · HL · contact PI
Haptoglobin 2 variant and endothelial glycocalyx shedding in sepsis-induced ARDS$560,853
R01 · FY2023 · HL · contact PI
Peri-operative factors that drive cell-free hemoglobin-mediated primary graft dysfunction$463,494
U01 · FY2023 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$460,343
T32 · FY2023 · HL · contact PI
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis$426,805
R01 · FY2023 · HL · contact PI
The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$228,122
R21 · FY2023 · GM
The MUltidimenSional phenotyping In Critical care (MUSIC) Consortium: A pathway to precision medicine at the bedside$194,260
U01 · FY2023 · HL · contact PI
Haptoglobin 2 variant and endothelial glycocalyx shedding in sepsis-induced ARDS$566,656
R01 · FY2022 · HL · contact PI
Peri-operative factors that drive cell-free hemoglobin-mediated primary graft dysfunction$486,276
U01 · FY2022 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$449,066
T32 · FY2022 · HL · contact PI
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis$445,056
R01 · FY2022 · HL · contact PI
The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$246,372
R21 · FY2022 · GM
Haptoglobin 2 variant and endothelial glycocalyx shedding in sepsis-induced ARDS$585,665
R01 · FY2021 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$353,094
T32 · FY2021 · HL · contact PI
The GOLD Study: Goal of Open Lung Ventilation in Donors$537,531
R01 · FY2020 · HL · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$511,205
R01 · FY2020 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$445,230
T32 · FY2020 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$160,315
K24 · FY2020 · HL · contact PI
The GOLD Study: Goal of Open Lung Ventilation in Donors$563,807
R01 · FY2019 · HL · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$511,205
R01 · FY2019 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$416,346
T32 · FY2019 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$160,975
K24 · FY2019 · HL · contact PI
The GOLD Study: Goal of Open Lung Ventilation in Donors$552,380
R01 · FY2018 · HL · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$501,431
R01 · FY2018 · HL · contact PI
Clinical and Translational Training Program in Pulmonary Medicine$425,151
T32 · FY2018 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$161,623
K24 · FY2018 · HL · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$140,254
R01 · FY2018 · HL · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$521,120
R01 · FY2017 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$162,258
K24 · FY2017 · HL · contact PI
The GOLD Study: Goal of Open Lung Ventilation in Donors$548,340
R01 · FY2016 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$162,880
K24 · FY2016 · HL · contact PI
The GOLD Study: Goal of Open Lung Ventilation in Donors$585,006
R01 · FY2015 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$161,445
K24 · FY2014 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$161,445
K24 · FY2013 · HL · contact PI
Inflammatory and epithelial injury markers for ARDS prognosis:A validation study$111,384
R21 · FY2013 · HL · contact PI
Treatment of Pulmonary Edema in Organ Donors$400,606
R01 · FY2012 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$161,445
K24 · FY2012 · HL · contact PI
Inflammatory and epithelial injury markers for ARDS prognosis:A validation study$117,000
R21 · FY2012 · HL · contact PI
Treatment of Pulmonary Edema in Organ Donors$437,279
R01 · FY2011 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$161,445
K24 · FY2011 · HL · contact PI
Treatment of Pulmonary Edema in Organ Donors$473,766
R01 · FY2010 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung Injury$158,315
K24 · FY2010 · HL · contact PI
Treatment of Pulmonary Edema in Organ Donors$469,956
R01 · FY2009 · HL · contact PI
Biomarker Profiles in the Diagnosis/Prognosis of ARDS$1,449,150
U01 · FY2008 · HL · contact PI
Treatment of Pulmonary Edema in Organ Donors$470,056
R01 · FY2008 · HL · contact PI
Biomarker Profiles in the Diagnosis/Prognosis of ARDS$1,529,109
U01 · FY2007 · HL · contact PI
Biomarker Profiles in the Diagnosis/Prognosis of ARDS$1,547,966
U01 · FY2006 · HL · contact PI
Biomarker Profiles in the Diagnosis/Prognosis of ARDS$44,334
U01 · FY2006 · HL · contact PI
Biomarker Profiles in the Diagnosis/Prognosis of ARDS$1,455,077
U01 · FY2005 · HL
Alveolar Epithelium in Acute Lung Injury$121,770
K08 · FY2005 · HL
Alveolar Epithelium in Acute Lung Injury$121,770
K08 · FY2004 · HL
Alveolar Epithelium in Acute Lung Injury$121,770
K08 · FY2003 · HL
Alveolar Epithelium in Acute Lung Injury$121,770
K08 · FY2002 · HL
Alveolar Epithelium in Acute Lung Injury$63,641
K08 · FY2001 · HL
Alveolar Epithelium in Acute Lung Injury$58,129
K08 · FY2001 · HL